The study, which began before states started legalizing cannabis, published its results on the impact of a legal cannabis environment on cannabis use and alcohol use disorder.
A peer-reviewed, longitudinal study recently published in the journal Psychological Medicine suggested that people who live in states where cannabis was legal experienced lower rates of alcohol use disorder (AUD) compared to those who lived in states where cannabis was illegal (1). The study, funded by grants from the National Institutes of Health, involved 240 pairs of twins (one twin living in a state with legalized cannabis, and the other twin in a state where cannabis was illegal) and sought to quantify the impact of recreational cannabis on substance use, day-to-day functioning, and whether vulnerable people are more susceptible to potential negative effects than others (1).
The “Results” section of the paper stated (2): “In the co-twin control design accounting for earlier cannabis frequency and alcohol use disorder symptoms respectively, the twin living in a recreational state used cannabis on average more often, and had fewer AUD symptoms than their co-twin living in a non-recreational state. Cannabis legalization was associated with no other adverse outcome in the co-twin design, including cannabis use disorder. No risk factor significantly interacted with legalization status to predict any outcome.”
“Recreational legalization was associated with increased cannabis use and decreased AUD symptoms, but was not associated with other maladaptations” (2), the authors of the study concluded. “Moreover, vulnerabilities to cannabis use were not exacerbated by the legal cannabis environment.”
The authors did acknowledge that not all outcomes typically associated with cannabis use were evaluated and that a broadly characterized sample population was used (1). In its conclusion, the study suggested that further research could investigate causal links between cannabis consumption and outcomes (2). “Prevention and intervention efforts may be best implemented by continuing to target established risk factors rather than focusing on availability,” they also concluded (1).
References
Ep 26: Innovations in Drying and Curing to Protect Flower Quality
May 27th 2025In this latest installment of Noid Knowledge, we are joined by Dr. Allison Justice, Founder and CEO of the Hemp Mine, and David Sandelman COO, CTO & Co-Founder of Cannatrol. Here, Allison and David discuss innovations in cannabis drying and curing, focusing on the Cannatrol technology which controls vapor pressure, preserving trichome integrity, and flower quality. Additionally, Allison shares how the Cannabis Research Center and Coalition (CRC) is transition to an open-source model to support cultivators, researchers, and home growers.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.